These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3136257)

  • 21. Comparative evaluation of aztreonam in therapy for experimental bacterial meningitis and cerebritis.
    Scheld WM; Brodeur JP; Foresman PA; Gratz JC; Rodeheaver GT
    Rev Infect Dis; 1985; 7 Suppl 4():S635-47. PubMed ID: 3909319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Laboratory and clinical studies on aztreonam in the pediatric field].
    Hosoda T; Masuda M; Miyao M
    Jpn J Antibiot; 1985 Nov; 38(11):3343-8. PubMed ID: 4094067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical study of aztreonam on respiratory tract infections caused by gram-negative pathogens].
    Shimokata K; Totani Y; Morishita M; Hashigami H; Yamamoto M; Suetsugu S; Tanaka A; Umeda H; Sakai S; Kobayashi T
    Jpn J Antibiot; 1985 Nov; 38(11):3415-33. PubMed ID: 3912526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical efficacy of aztreonam in refractory infections in children].
    Ogura H; Hamada F; Fujieda M; Matsumoto K; Araki K; Ogura Y; Kuramitsu M; Kurashige T; Kitamura I
    Jpn J Antibiot; 1985 Nov; 38(11):3349-57. PubMed ID: 4094068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical experience with aztreonam in the pediatric field].
    Kobashi H; Aihara R; Nishioka A; Oohara K; Okamoto T
    Jpn J Antibiot; 1985 Nov; 38(11):3316-22. PubMed ID: 4094064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetics and clinical evaluations on aztreonam in perinatal infections in obstetrics and gynecology. A study of aztreonam in the perinatal co-research group].
    Matsuda S; Oh K; Hirayama H; Shimizu T; Sengoku K; Haga H; Inoue R; Yamazaki T; Mizoguchi H; Tori-i Y
    Jpn J Antibiot; 1990 Apr; 43(4):736-53. PubMed ID: 2199691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetic and clinical studies on aztreonam in neonates and premature infants].
    Sunakawa K; Ishizuka Y; Saito N; Akita H; Iwata S; Sato Y; Oikawa T
    Jpn J Antibiot; 1990 Mar; 43(3):413-23. PubMed ID: 2374294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies of aztreonam in neonates].
    Sato H; Narita A; Suzuki H; Nakazawa S; Matsumoto K; Nakanishi Y; Niino K; Nakazawa S
    Jpn J Antibiot; 1990 Mar; 43(3):445-54. PubMed ID: 2374296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Laboratory and clinical studies of aztreonam in the pediatric field].
    Nishimura T; Tabuki K; Takashima T; Takagi M
    Jpn J Antibiot; 1985 Nov; 38(11):3300-6. PubMed ID: 4094062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients.
    Trujillo H; Harry N; Arango A; Benítez G; Restrepo F; Mejía GI; Castrillón AL
    Chemotherapy; 1989; 35 Suppl 1():25-30. PubMed ID: 2731447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical features and evaluation of initial antibiotic treatment in 125 cases with purulent meningitis in infancy and childhood].
    Taneda Y; Iwai N; Nakamura H
    Jpn J Antibiot; 1991 Mar; 44(3):303-16. PubMed ID: 1880912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical evaluation of aztreonam in children].
    Ito S; Mikawa H; Mochizuki Y; Ohkubo H; Yoshida A
    Jpn J Antibiot; 1985 Nov; 38(11):3285-93. PubMed ID: 4094060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetics and clinical studies on aztreonam in neonates].
    Arai S; Sono R; Shibata T; Sakurai M; Ihara T; Kamiya H; Inamochi H; Nomura T; Taki N; Suzuki M
    Jpn J Antibiot; 1990 Mar; 43(3):479-86. PubMed ID: 2374297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacokinetics and clinical safety of aztreonam in neonates].
    Azagami S; Isohata E; Oikawa T; Osano M; Shiro H
    Jpn J Antibiot; 1990 Mar; 43(3):405-12. PubMed ID: 2374293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacokinetic and clinical evaluation of aztreonam in neonates and premature infants].
    Toyonaga Y; Sugita M; Nakamura H; Kawamura K; Seo K
    Jpn J Antibiot; 1990 Mar; 43(3):425-43. PubMed ID: 2374295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different meningitis-causing bacteria induce distinct inflammatory responses on interaction with cells of the human meninges.
    Fowler MI; Weller RO; Heckels JE; Christodoulides M
    Cell Microbiol; 2004 Jun; 6(6):555-67. PubMed ID: 15104596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aztreonam in the treatment of gram-negative meningitis in children.
    Isani Z; Rehman N; Adil N; el Messidi M
    Chemioterapia; 1987 Jun; 6(2 Suppl):428-30. PubMed ID: 3334590
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical trial of aztreonam in the field of obstetrics and gynecology].
    Tateno M; Maruyama C
    Jpn J Antibiot; 1985 Dec; 38(12):3599-605. PubMed ID: 3834144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cerebrospinal meningitis and encephalitis in 1992].
    Zabicka J
    Przegl Epidemiol; 1994; 48(1-2):79-87. PubMed ID: 8073149
    [No Abstract]   [Full Text] [Related]  

  • 40. [Biological characteristic of the main pathogens in purulent bacterial meningitis].
    Vlasova IV; Ershikova IuE; Svistunova TS; Sidorenko SV; Stoliarova LG
    Antibiot Khimioter; 2002; 47(10):13-24. PubMed ID: 12674790
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.